Media coverage about CME Group (NASDAQ:CME) has been trending somewhat positive recently, Accern reports. Accern rates the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CME Group earned a daily sentiment score of 0.14 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 45.9673319626092 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the media stories that may have effected Accern Sentiment’s scoring:
- Big Changes May Be Coming for the Treasury Market – Bloomberg (bloomberg.com)
- Form 8.3 – CME Group Inc. – London South East (blog) (lse.co.uk)
- Expect A Hawkish Fed; So Bad News For Gold? – CME Group – Kitco News (kitco.com)
- CME Group Inc. Announces First-Quarter 2018 Earnings Release, Conference Call – Exchange News Direct (mondovisione.com)
- Dimensional Fund Advisors Ltd. : Form 8.3 – CME Group Inc. – Common stock (globenewswire.com)
Shares of CME stock traded up $0.32 during trading hours on Wednesday, hitting $164.50. 1,186,081 shares of the company were exchanged, compared to its average volume of 1,756,927. The stock has a market cap of $55,666.56, a P/E ratio of 13.78, a P/E/G ratio of 2.43 and a beta of 0.54. CME Group has a 52 week low of $114.82 and a 52 week high of $171.71. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.10.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be given a dividend of $0.70 per share. The ex-dividend date is Thursday, March 8th. This is a boost from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a dividend yield of 1.70%. CME Group’s dividend payout ratio is currently 23.45%.
CME has been the topic of a number of recent analyst reports. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 6th. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective for the company in a research note on Tuesday, January 2nd. Berenberg Bank assumed coverage on shares of CME Group in a research note on Thursday, January 25th. They issued a “hold” rating and a $170.00 price objective for the company. Citigroup reiterated a “buy” rating and issued a $172.00 price objective (up previously from $155.00) on shares of CME Group in a research note on Monday, January 29th. Finally, Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price objective on shares of CME Group in a research note on Friday, February 2nd. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $157.77.
In other CME Group news, insider Derek Sammann sold 2,400 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $161.66, for a total transaction of $387,984.00. Following the transaction, the insider now directly owns 40,153 shares in the company, valued at $6,491,133.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 200 shares of the stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total transaction of $31,982.00. Following the transaction, the director now owns 3,809 shares in the company, valued at $609,097.19. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 40,699 shares of company stock worth $6,266,062. Company insiders own 0.57% of the company’s stock.
WARNING: This piece of content was originally published by BBNS and is the property of of BBNS. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://baseballnewssource.com/2018/03/21/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-cme-group-cme-share-price/2030809.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.